PT - JOURNAL ARTICLE AU - Johannsen, Anna L. AU - Danowski, Morgan E. AU - Sitter, Kailyn E. AU - Preys, Charlene L. AU - Gerety, Haley C. AU - Brunette, Charles A. AU - Christensen, Kurt D. AU - Gaziano, J. Michael AU - Knowles, Joshua W. AU - Muralidhar, Sumitra AU - Sturm, Amy C. AU - Sun, Yan V. AU - Whitbourne, Stacey B. AU - Yi, Thomas AU - the VA Million Veteran Program AU - Vassy, Jason L. TI - Primary Care Providers’ Perspectives on Receiving Tier 1 Genomic Results from a National Study – the Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study AID - 10.1101/2024.10.29.24316065 DP - 2024 Jan 01 TA - medRxiv PG - 2024.10.29.24316065 4099 - http://medrxiv.org/content/early/2024/11/01/2024.10.29.24316065.short 4100 - http://medrxiv.org/content/early/2024/11/01/2024.10.29.24316065.full AB - Background Patients are increasingly obtaining genetic health information and integrating it into their care with the help of their primary care provider (PCP). However, PCPs may not be adequately prepared to effectively utilize genetic results . Across the VA health system, the Million Veteran Program-Return of Actionable Results-Familial Hypercholesterolemia (MVP-ROAR) study clinically confirms and returns genetic results associated with familial hypercholesterolemia (FH), identified in a national biobank program.Methods PCPs who received their patient’s genetic results through the MVP-ROAR Study were invited to participate in semi-structured interviews, which explored PCPs’ familiarity with FH, how the results impacted medical management, and suggestions for process improvement. Interviews were transcribed and analyzed using directed content analysis and constant comparison methods to identify key themes.Results Interviews with nine PCPs revealed varied levels of familiarity with genetic testing and FH. Most PCPs did not distinguish FH from common high cholesterol issues and already used similar treatment approaches. Many PCPs did not recall receiving results from the MVP-ROAR Study. Alerts in medical records were deemed effective for communicating results. PCPs valued genetics in informing patient care and identifying at-risk family members but noted several implementation barriers, such as additional workload and unclear medical management benefits. Recommendations for improving results disclosure included simplifying the genetic testing report and associated support documents.Conclusion The study represents the first investigation into PCPs’ experiences with receiving genetic test results from a biobank linked to a national healthcare system. Results suggest that PCPs generally view genetic testing as beneficial, though they may not significantly alter medical management. PCPs expressed that integrating genetics into routine care may be burdensome and require additional training, which may not be practical. The study underscores the need for accessible genetic information, which could be aided by specialized support roles or different clinical specialties assisting with incorporating genetic results into patient care.Competing Interest StatementKDC was supported by a research grant from Sanford Health. ACS is an employee of 23andMe, Inc. All other authors report no competing interests.Funding StatementThis research is based on data from the Million Veteran Program, Office of Research and Development, Veterans Health Administration, and was supported by award number MVP030. This publication does not represent the views of the Department of Veteran Affairs or the United States Government. The authors thank Ella Ransbottom, Annika Toivonen, Camille Amaditz, and Rosalina Caliri for assistance with data collection, figure preparation, and reference organization.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The VA Central IRB gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.